Business, Policy & Funding
Breaking news on diagnostics business, policy, and funding.
GeneDx Stock Plummets Despite 42 Percent Q1 Revenue Growth
The company reported a 42 percent year-over-year increase in first quarter revenues, driven by continuing strong demand for whole-genome and whole-exome testing.
The company said that its test could overcome sensitivity issues with ultrasound and serum alpha-fetoprotein assays that are used to monitor at-risk patients.
Octave Bioscience Gets NY State Certification for MS Test
With the certification from the NYS Clinical Laboratory Evaluation Program, the company said the test is now available throughout the US.
Spain's DeepUll Raises €50M in Oversubscribed Series C Financing Round
The funds will help the company finalize clinical trials for its automated molecular rapid sepsis pathogen identification and antimicrobial susceptibility testing system.
Quanterix, Akoya Biosciences Amend Merger Agreement
The change to the terms of the deal follows opposition by some shareholders to the original agreement.